Navigation Links
Role of hormones, potential new treatments topic of UH lecture
Date:9/7/2012

While estrogen is essential for many of the body's normal processes in both men and women, it also plays a role in diseases such as breast, ovarian and prostate cancer. The impact of this hormone on such diseases will be addressed during a lecture Sept. 25 at the University of Houston (UH).

Dr. Jan-ke Gustafsson, biochemistry professor and director of the Center for Nuclear Receptors and Cell Signaling at UH, will present "Hormones in Health and Disease." He will be the third speaker in a UH lecture series highlighting the impact of science on health and society.

The lecture will focus on the discovery and functions of estrogen receptor beta (ERbeta) and its impact on drug delivery and disease. A steroid hormone found in both males and females, estrogen binds to and activates the estrogen receptors, triggering the regulation of gene expression.

In 1995, Gustafsson and his research group discovered there are two estrogen receptors instead of one. The discovery of ERbeta was a major and unexpected breakthrough. He is now proving the theories arising from that initial discovery. Due to its broad influence in the human body, ERbeta is a premier target for drug delivery and therapies.

"Estrogen and estrogen receptors are found in tissues ranging from the central nervous system, to breast tissue and the cardiovascular system," Gustafsson said. "ERbeta also regulates functions in the ovary, testis, prostate, kidney, bone and colon. Today, researchers are exploring the receptor as a target for drugs in treatments of neurological diseases, psychological disorders and cancer."

Sponsored by the College of Natural Sciences and Mathematics (NSM), the Friends of NSM Distinguished Lecture Series features leading scientists and physicians addressing breakthroughs in science that will alter the prevention, diagnosis and treatment of diseases, as well as impact the delivery of medical care. The lectures are free and open to the public.

WHO:

Jan-ke Gustafsson, M.D., Ph.D.

Robert A. Welch Professor of Chemistry

Director, Center for Nuclear Receptors and Cell Signaling at UH

WHAT:

Lecture: "Hormones in Health and Disease"

Friends of NSM Distinguished Lecture Series: Science Impacting Health and Society

WHEN:

7 8 p.m., Tuesday, Sept. 25

WHERE:

University of Houston
Rockwell Pavilion, second floor of the UH M.D. Anderson Library
Off Calhoun Road, Entrance 1
Map: http://www.friends.nsm.uh.edu/directions


'/>"/>

Contact: Lisa Merkl
lkmerkl@uh.edu
713-743-8192
University of Houston
Source:Eurekalert  

Related medicine news :

1. PharmaNet system dramatically reduced inappropriate prescriptions of potentially addictive drugs
2. Cleveland Clinic researchers investigating potential drug for treatment of Alzheimers disease
3. US performs worst on potentially preventable death rates compared to France, Germany, and the UK
4. Could a cancer drug potentially prevent learning disabilities in some kids?
5. Earphones potentially as dangerous as noise from jet engines, according to new study
6. Diagnostic test shows potential to noninvasively identify significant coronary artery disease
7. CSI technology holds potential in everyday medicine
8. Potential new treatment target identified for melanoma skin cancer
9. Potential Nipah vaccine passes primate test
10. Researchers find potential cancer roadblock
11. Early treatment could mean greater earning potential for people with HIV
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Role of hormones, potential new treatments topic of UH lecture
(Date:5/29/2017)... ... ... The quest to develop a cure for HIV has long been plagued by ... has a knack for lying dormant in immune cells at levels undetectable to all ... Graduate School of Public Health announced today in Nature Medicine that they’ve created a ...
(Date:5/28/2017)... Melbourne, FL (PRWEB) , ... May 28, 2017 ... ... Partners of America (PPOA), is proud to announce that Jorge Fernandez-Silva, M.D., has ... comprehensive interventional pain management, a specialty that concentrates on minimally invasive techniques to ...
(Date:5/27/2017)... ... May 26, 2017 , ... A May 8 article ... for colds or respiratory issues that are not responsive to antibiotics nevertheless obtain prescriptions ... may be largely responsible for the problem both in Canada and the United States. ...
(Date:5/27/2017)... ... May 27, 2017 , ... From May 21-23, hearing healthcare professionals ... event was held at the Marriott Syracuse Downtown Hotel in Syracuse, New York. ... network of independent hearing healthcare providers to help them stay ahead in the industry. ...
(Date:5/26/2017)... ... May 26, 2017 , ... The American Parkinson Disease Association’s ... eighty-nine grant submissions all vying for nearly $1,000,000 in funding that will be ... The American Parkinson Disease Association (APDA) is focused on advancing scientific research that ...
Breaking Medicine News(10 mins):
(Date:5/23/2017)... , May 23, 2017  Leaf Healthcare, ... innovative medical devices for pressure ulcer prevention, will ... American Association of Critical Care Nurses, National Teaching ... 22-25. The Leaf Patient Monitoring System ... for the hospital environment.  The system seamlessly tracks ...
(Date:5/18/2017)... 18, 2017  Two Bayer U.S. Pharmaceutical leaders received ... its recent 28 th Woman of the ... showcases HBA,s longstanding mission of furthering the advancement and ... Cindy Powell-Steffen , senior director of brand ... and Libby Howe , a regional business manager ...
(Date:5/15/2017)... 15, 2017 Enterin Inc., a privately-held CNS pharmaceutical ... novel compounds to treat Parkinson,s disease (PD), has enrolled the ... Phase 1/2a randomized, controlled, multicenter study involving patients with PD ... 50 patients over a 9-to-12-month period. The first stage is ... with PD. Participating sites include Denver , ...
Breaking Medicine Technology: